AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,472,000 | +96715.3% | 450,000 | 0.0% | 5.81% | +5.3% |
| Q2 2023 | $5,652 | +13.2% | 450,000 | 0.0% | 5.51% | -7.0% |
| Q1 2023 | $4,991 | -9.2% | 450,000 | 0.0% | 5.93% | -9.7% |
| Q4 2022 | $5,495 | -99.9% | 450,000 | 0.0% | 6.56% | +25.1% |
| Q3 2022 | $4,698,000 | -2.8% | 450,000 | 0.0% | 5.24% | +1.9% |
| Q2 2022 | $4,833,000 | +13.4% | 450,000 | 0.0% | 5.14% | +43.8% |
| Q1 2022 | $4,262,000 | -18.0% | 450,000 | 0.0% | 3.58% | -8.9% |
| Q4 2021 | $5,198,000 | +20.9% | 450,000 | 0.0% | 3.93% | +22.5% |
| Q3 2021 | $4,298,000 | -0.9% | 450,000 | 0.0% | 3.20% | +2.2% |
| Q2 2021 | $4,338,000 | -2.4% | 450,000 | 0.0% | 3.14% | -5.1% |
| Q1 2021 | $4,446,000 | +114.0% | 450,000 | +400.0% | 3.30% | +71.5% |
| Q4 2020 | $2,078,000 | – | 90,000 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |